Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Study of the Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer

Trial Profile

Pilot Study of the Preoperative Combination of Pembrolizumab and Radiation Therapy in Patients With Operable Breast Cancer

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 27 Nov 2018

At a glance

  • Drugs Pembrolizumab (Primary)
  • Indications Adenocarcinoma; Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2018 Planned number of patients changed from 20 to 30.
    • 16 Nov 2018 Planned End Date changed from 30 Dec 2018 to 30 Dec 2019.
    • 16 Nov 2018 Planned primary completion date changed from 30 Dec 2018 to 30 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top